IL1B and neoplasm: On the other hand, tumor growth may be associated with the progressive inhibition of NF-κB and in the progressive development of M2 inflammation, characterized by low levels of TNF-α, IL-1, and IL-12, and high levels of IL-10 and TGF-β [120].